These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19912517)

  • 21. Management of Philadelphia negative chronic myeloproliferative disorders in pregnancy.
    Griesshammer M; Struve S; Barbui T
    Blood Rev; 2008 Sep; 22(5):235-45. PubMed ID: 18617299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Essential thrombocythemia in pregnancy: platelet count and pregnancy outcome.
    Chow EY; Haley LP; Vickars LM
    Am J Hematol; 1992 Dec; 41(4):249-51. PubMed ID: 1288286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extreme thrombocytosis in low-risk essential thrombocythemia: Retrospective review of vascular events and treatment strategies.
    Tefferi A; Szuber N; Pardanani A; Hanson CA; Vannucchi AM; Barbui T; Gangat N
    Am J Hematol; 2021 Jun; 96(6):E182-E184. PubMed ID: 33617676
    [No Abstract]   [Full Text] [Related]  

  • 24. Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation.
    Passamonti F; Randi ML; Rumi E; Pungolino E; Elena C; Pietra D; Scapin M; Arcaini L; Tezza F; Moratti R; Pascutto C; Fabris F; Morra E; Cazzola M; Lazzarino M
    Blood; 2007 Jul; 110(2):485-9. PubMed ID: 17426257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation.
    Alvarez-Larrán A; Pereira A; Guglielmelli P; Hernández-Boluda JC; Arellano-Rodrigo E; Ferrer-Marín F; Samah A; Griesshammer M; Kerguelen A; Andreasson B; Burgaleta C; Schwarz J; García-Gutiérrez V; Ayala R; Barba P; Gómez-Casares MT; Paoli C; Drexler B; Zweegman S; McMullin MF; Samuelsson J; Harrison C; Cervantes F; Vannucchi AM; Besses C
    Haematologica; 2016 Aug; 101(8):926-31. PubMed ID: 27175028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of interferon alpha for essential thrombocythemia during pregnancy: two cases and a literature review.
    Sakai K; Ueda A; Hasegawa M; Ueda Y
    Int J Hematol; 2018 Aug; 108(2):203-207. PubMed ID: 29290077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anagrelide: what was new in 2004 and 2005?
    Petrides PE
    Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):399-408. PubMed ID: 16810615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and histological characteristics of livedo racemosa in essential thrombocythemia: A report of two cases and review of the published works.
    Inoue S; Okiyama N; Okune M; Shiraki N; Kessoku R; Fujimoto M
    J Dermatol; 2017 Jan; 44(1):84-87. PubMed ID: 27570091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon-alfa treatment of essential thrombocythemia during pregnancy.
    Iwashita T; Fujitani M; Yamamoto Y; Katsurada T; Yoshida Y
    Intern Med; 2006; 45(20):1161-4. PubMed ID: 17106162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful pregnancies after recurrent abortions in mild essential thrombocythemia.
    Kaaja RJ; Leinonen PJ
    Acta Obstet Gynecol Scand; 1998 Nov; 77(10):1022-3. PubMed ID: 9849849
    [No Abstract]   [Full Text] [Related]  

  • 31. [A case of pregnancy with essential thrombocythemia].
    Yamamoto R; Hirahatake K; Yamaguchi M; Sato C
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Mar; 47(3):279-82. PubMed ID: 7699288
    [No Abstract]   [Full Text] [Related]  

  • 32. Essential thrombocythemia: scientific advances and current practice.
    Tefferi A
    Curr Opin Hematol; 2006 Mar; 13(2):93-8. PubMed ID: 16456375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ADP-induced platelet aggregation and thrombin generation are increased in Essential Thrombocythemia and Polycythemia Vera.
    Panova-Noeva M; Marchetti M; Russo L; Tartari CJ; Leuzzi A; Finazzi G; Rambaldi A; ten Cate H; Falanga A
    Thromb Res; 2013 Jul; 132(1):88-93. PubMed ID: 23735588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of interferon-alpha in essential thrombocythemia during pregnancy.
    Yoshida Y; Katsurada T; Nakabou Y; Kawabata H
    Ann Hematol; 2017 May; 96(5):877-878. PubMed ID: 28194492
    [No Abstract]   [Full Text] [Related]  

  • 35. Alpha 2b-interferon therapy and pregnancy--report of a case of essential thrombocythemia.
    Pardini S; Dore F; Murineddu M; Bontigli S; Longinotti M; Grigliotti B; Spano B
    Am J Hematol; 1993 May; 43(1):78-9. PubMed ID: 8317474
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacotherapy of essential thrombocythemia.
    Gangat N; Tefferi A
    Expert Opin Pharmacother; 2008 Jul; 9(10):1679-85. PubMed ID: 18570601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First successful pregnancy outcome after intrauterine insemination in a woman with primary infertility and essential thrombocythemia treated with interferon-alpha and aspirin.
    Leković D; Gotić M; Ljubić A
    Srp Arh Celok Lek; 2015; 143(3-4):210-3. PubMed ID: 26012134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pegylated interferon alpha-2a for essential thrombocythemia during pregnancy: outcome and safety. A case series.
    Beauverd Y; Radia D; Cargo C; Knapper S; Drummond M; Pillai A; Harrison C; Robinson S
    Haematologica; 2016 May; 101(5):e182-4. PubMed ID: 26819057
    [No Abstract]   [Full Text] [Related]  

  • 39. Practical approach to treating essential thrombocythaemia: case studies.
    Reilly JT
    Eur J Haematol Suppl; 2007 Oct; (68):40-2. PubMed ID: 17727566
    [No Abstract]   [Full Text] [Related]  

  • 40. Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management.
    Tefferi A; Barbui T
    Am J Hematol; 2015 Feb; 90(2):162-73. PubMed ID: 25611051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.